110P Outcomes of CUPem: A prospective phase II multicentre clinical trial of pembrolizumab in patients with pre-treated cancer of unknown primary H.S. Wasan,S. Rao, S. Ngan, C. Matei, A.R. Sita-Lumsden, L. Webber, J. Mencel, R. Elliott, J. Lozano-KuehneImmuno-Oncology and Technology（2023）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
